LEADER 03821nam  22008415  450 
001 9910298262803321
005 20230810184959.0
010   $a3-319-25543-6
024 7 $a10.1007/978-3-319-25543-9
035   $a(CKB)3710000000486782
035   $a(EBL)4178576
035   $a(SSID)ssj0001583188
035   $a(PQKBManifestationID)16258773
035   $a(PQKBTitleCode)TC0001583188
035   $a(PQKBWorkID)14862103
035   $a(PQKB)10352258
035   $a(DE-He213)978-3-319-25543-9
035   $a(MiAaPQ)EBC4178576
035   $a(PPN)190536500
035   $a(EXLCZ)993710000000486782
100   $a20151007d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aEmerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments /$fedited by Anne C. La Flamme, Jacqueline Monique Orian
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (244 p.)
225 1 $aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v26
300   $aDescription based upon print version of record.
311   $a3-319-25541-X 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aHLA in MS. Helminth therapy for MS -- Sex differences in MS I -- Sex differences in MS II -- Environment and MS Biomarkers in MS -- Photoimmunology and regulation of disease in MS -- Modeling MS pathology -- Vitamin D. b-amyloid proteins and MS.
330   $aOver the past decade, we have made great advances in the field of multiple sclerosis (MS) research, and this book focuses on those advances in MS pathogenesis and treatment. While some of these advances have been through new approaches and ideas that have emerged in the last decade such as the newly identified protective role that amyloid proteins may play in MS or the use of helminths to treat autoimmune diseases, others have evolved from previous theories and ideas that have only now gained momentum and a deeper understanding such as the role of HLA or gender in MS susceptibility. This book covers these emerging and evolving topics and highlights the substantial advancements made in elucidation of the factors regulating susceptibility or disease progression, identification of new ways to monitor or predict MS pathology, and development of new strategies for treating MS.
410  0$aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v26
606   $aMedical genetics
606   $aNeurosciences
606   $aImmunology
606   $aMedicine$xResearch
606   $aBiology$xResearch
606   $aNervous system$xRadiography
606   $aNeurology
606   $aMedical Genetics
606   $aNeuroscience
606   $aImmunology
606   $aBiomedical Research
606   $aNeuroradiology
606   $aNeurology
615  0$aMedical genetics.
615  0$aNeurosciences.
615  0$aImmunology.
615  0$aMedicine$xResearch.
615  0$aBiology$xResearch.
615  0$aNervous system$xRadiography.
615  0$aNeurology.
615 14$aMedical Genetics.
615 24$aNeuroscience.
615 24$aImmunology.
615 24$aBiomedical Research.
615 24$aNeuroradiology.
615 24$aNeurology.
676   $a616.834
702   $aLa Flamme$b Anne C$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aOrian$b Jacqueline Monique$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910298262803321
996   $aEmerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments$92531254
997   $aUNINA